|国家预印本平台
首页|Let's play POLO: Integrating the probability of lesion origin into proton treatment plan optimization for low-grade glioma patients

Let's play POLO: Integrating the probability of lesion origin into proton treatment plan optimization for low-grade glioma patients

Let's play POLO: Integrating the probability of lesion origin into proton treatment plan optimization for low-grade glioma patients

来源:Arxiv_logoArxiv
英文摘要

In proton therapy of low-grade glioma (LGG) patients, contrast-enhancing brain lesions (CEBLs) on magnetic resonance imaging are considered predictive of late radiation-induced lesions. From the observation that CEBLs tend to concentrate in regions of increased dose-averaged linear energy transfer (LET) and proximal to the ventricular system, the probability of lesion origin (POLO) model has been established as a multivariate logistic regression model for the voxel-wise probability prediction of the CEBL origin. To date, leveraging the predictive power of the POLO model for treatment planning relies on hand tuning the dose and LET distribution to minimize the resulting probability predictions. In this paper, we therefore propose automated POLO model-based treatment planning by directly integrating POLO calculation and optimization into plan optimization for LGG patients. We introduce an extension of the original POLO model including a volumetric correction factor, and a model-based optimization scheme featuring a linear reformulation of the model together with feasible optimization functions based on the predicted POLO values. The developed framework is implemented in the open-source treatment planning toolkit matRad. Our framework can generate clinically acceptable treatment plans while automatically taking into account outcome predictions from the POLO model. It also supports the definition of customized POLO model-based objective and constraint functions. Optimization results from a sample LGG patient show that the POLO model-based outcome predictions can be minimized under expected shifts in dose, LET, and POLO distributions, while sustaining target coverage ($\Delta_{\text{PTV}} \text{d95}_{RBE,fx}\approx{0.03}$, $\Delta_{\text{GTV}} \text{d95}_{RBE,fx}\approx{0.001}$), even at large NTCP reductions of $\Delta{\text{NTCP}}\approx{26}\%$.

Tim Ortkamp、Habiba Sallem、Semi Harrabi、Martin Frank、Oliver J?kel、Julia Bauer、Niklas Wahl

肿瘤学医学研究方法

Tim Ortkamp,Habiba Sallem,Semi Harrabi,Martin Frank,Oliver J?kel,Julia Bauer,Niklas Wahl.Let's play POLO: Integrating the probability of lesion origin into proton treatment plan optimization for low-grade glioma patients[EB/OL].(2025-06-16)[2025-06-23].https://arxiv.org/abs/2506.13539.点此复制

评论